ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2,1,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
2,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2,3,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
2,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2,5,Scleral discolouration,"Scleral structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
3,1,Corneal erosion,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
3,2,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
4,1,Capillary fragility increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
5,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
6,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
8,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
9,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
9,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
10,2,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
11,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
12,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
13,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
14,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
14,2,Keratopathy,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
14,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
14,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
15,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
15,2,Erythema of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
15,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
15,4,Lacrimal disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
15,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
15,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
16,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
16,2,Erythema of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
16,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
16,4,Hyperaemia,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
16,5,Lacrimal disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
16,6,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
16,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
17,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
17,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
18,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
18,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
19,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
19,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
19,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
20,1,Injection site extravasation,Injection site reactions,Administration site reactions,Genrl,N
20,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
21,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
21,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
21,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
21,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
22,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
22,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
22,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
22,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
24,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
24,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
25,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
